COMMUNIQUÉS West-GlobeNewswire

Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene Therapy
20/10/2025
-- Poster to be presented at American College of Rheumatology Convergence 2025 – BRISBANE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to [...]
Anresco Laboratories and NJ Labs Unite to Form Nationwide Testing Network Built on Trusted, Proven Expertise
20/10/2025
LAS VEGAS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Anresco Laboratories and NJ Labs —two of the nation’s most established analytical laboratories—have joined forces to establish Anresco NJ Labs , a nationwide network uniting [...]
Noom Launches AI Face Scan and AI Future Me to Bring Preventive Health Insights to Everyone
20/10/2025
Using AI and a smartphone camera, Noom makes personalized health screening and motivational tools accessible to all for free Noom’s free Face Scan feature PRINCETON, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Noom , the [...]
ThrIVe Health Announces Patient Education Seminar Featuring Leading Thyroid Eye Disease Specialist Dr. Raymond Douglas
20/10/2025
World-Renowned Oculoplastic Surgeon Dr. Raymond Douglas and Board-Certified Endocrinologist Dr. Gladys E. Palomeno to Address Patients, Caregivers, and Healthcare Professionals Beverly Hills, CA, Oct. 20, 2025 (GLOBE [...]
IMPALA Appoints Ann Marie Dunne as New Chair, Succeeding Jonathan Taylor
20/10/2025
PISCATAWAY, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- IMPALA, a global consortium dedicated to advancing digital and analytics-driven quality in biopharmaceutical development, announced the appointment of Ann Marie Dunne [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
20/10/2025
One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy in 16 patients with metastatic uveal melanoma in the ongoing Phase 1b trial continues to show strong clinical benefit with more mature [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
20/10/2025
Taipei, Taiwan, Oct. 20, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Solana Company Executive Chairman’s Message: October 20th, 2025
20/10/2025
NEWTOWN, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Today, Solana Company (NASDAQ: HSDT) released the following letter from the Executive Chairman: We are excited to enter the next phase of our lifecycle with a strong [...]
AIM ImmunoTech to Attend the 2025 Maxim Growth Summit
20/10/2025
OCALA, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced it will participate at the 2025 Maxim Growth Summit , taking place October 22-23, 2025 in [...]
Eleos to Launch Polaris AI Advanced, Purpose-Built Foundational AI Model for Post-Acute Care, built with Google Cloud Technology
20/10/2025
Polaris AI leverages Google Cloud’s Gemini family of multimodal models and Eleos’ secure and clinically validated infrastructure to reduce documentation burden, strengthen compliance and help providers focus on care. [...]
ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025
20/10/2025
SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, announced today that it will present initial [...]
VitalHub Announces Q3 2025 Conference Call Date
20/10/2025
TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for its third quarter 2025 ended September 30, 2025 [...]
Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials
20/10/2025
ADELAIDE, Australia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Avance Clinical , the Australia-based global CRO partner for biotechs, has been a leader in early phase clinical research for more than 30 years. With operations [...]
AAMI and TechNation Collaborate to Survey HTM Field
20/10/2025
Survey will assess demographics, salary rates, more Arlington, Virginia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Soon, the health technology community will have fresh insights and previously unknown data about some of its [...]
OneMedNet Welcomes Our Latest Subscriber mlHealth360
20/10/2025
MINNEAPOLIS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced today that mlHealth360, a healthcare AI and [...]
Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn’s Disease (FSCD)
20/10/2025
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and PD data anticipated in Q1 2026 Advances ongoing development of PALI [...]

Pages